Insight Pharma Reports
Menu
 
 
 
 
 
 
 
 
banner

Insight Pharma Reports

Expert Intelligence For Better Decisions

Insight Pharma Reports is the leading source for industry reports. Please browse our selection of quality publications!

LATEST REPORTS

Analytics of the Microbiome Landscape
From $7,000.00
Biosimilars: US Payer Insights 2020
From $3,295.00
Digital Health and the Management of Chronic Disease
From $3,295.00
COVID-19: A Major Review of How to Protect the Entire Pharma Supply Chain
From $2,500.00
COVID-19 Implications for pharma: US payer insights
From $1,195.00
Biopharmaceutical Venture Capital Trends: Coronavirus Disease (COVID-19) Company Impact Report
From $695.00
Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective
From $2,350.00
Social Media: Coronavirus Disease (COVID-19) Sector Impact
From $846.00
Trends in Digital Physician Engagement
From $3,295.00
Coronavirus Disease 2019 (COVID-19) - Pipeline Review, H1 2020
From $2,500.00
Digital Technologies: New Strategies for Customer Engagement
From $3,295.00
Coronavirus outbreak: Impact on complex global supply chains and beyond
From $846.00
COVID-19: Analysis of the Emerging Disease Landscape
From $2,495.00
Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast
From $1,995.00
Coronavirus Disease (COVID-19): Epidemiology Analysis and Forecast
From $1,995.00
The Future of Personalized Medicine: The Role of Simulation and Digital Twins
From $995.00
Global Cancer Monoclonal Antibody Partnering Terms and Agreements 2014-2020
From $3,495.00
Heart Failure: Global Drug Forecast and Market Analysis to 2028
From $7,697.00
US Home Healthcare Market Outlook 2020
From $1,000.00
IoT Market Forecast and Growth Opportunities
From $2,621.00
Global Telemedicine Market Outlook 2022
From $1,800.00
2020 Global Respiratory Disease Testing Market: US, Europe, Japan--Supplier Shares and Sales Segment Forecasts--Adenovirus, Coronavirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis
From $7,500.00
2020 Global Coronavirus Diagnostics Market: US, Europe, Japan--Supplier Shares, Sales Segment Forecasts, Innovative Technologies and Tests, Competitive Profiles and Strategies
From $3,850.00
Blockchain in Oil & Gas - Thematic Research
From $1,950.00
Blockchain in Metals & Mining - Thematic Research
From $1,950.00
Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2014-2019
From $2,995.00
Commercializing Novel IVDs: A Comprehensive Manual for Success 2019 Supplement
From $199.00
Global Antibiotics Partnering Terms and Agreements 2010 to 2020
From $3,495.00
Report Package Immuno-Oncology: Inhibitory and Stimulatory Immunomodulators
From $1,642.00
Monoclonal Antibodies: Probes for The Study of Autoimmunity and Immunodeficiency
From $72.95
Artificial Intelligence and Machine Learning: Applications in Pharma
From $445.00
Real World Data and Evidence: Payer Insights
From $2,625.00
Global Gene Therapy Partnering Terms and Agreements 2014 to 2020
From $3,495.00
Blockbuster Biologics 2019: Sales of Recombinant Therapeutic Antibodies & Proteins
From $97.33
The Future of CRISPR
From $445.00
Trends in Digital Pharma Marketing
From $1,595.00
Marketing to Life Scientists: Second Edition
From $995.00
Global Antibody Partnering
From $3,495.00
Global Artificial Intelligence (AI) Partnering Terms and Agreements 2010 to 2020
From $3,495.00
Paying for Digital Health: Payer Insights
From $2,495.00
New Commercial Models: Benchmarking Pharma Companies
From $2,495.00
Benchmarking Pharma's MSL Capabilities
From $2,495.00
Succeeding with value based contracts
From $2,495.00
Blockchain: Transformational change for Pharma?
From $395.00
Pricing and Reimbursement in Neurology
From $2,375.00
Huntingtin (Huntington Disease Protein or HTT) - Pipeline Review, H2 2018
From $3,500.00
E3 Ubiquitin Protein Ligase XIAP
From $3,500.00
Ubiquitin conjugating enzyme Inhibitor -Pipeline Insight, 2018
From $1,250.00
Ubiquitin Specific Proteases (USP) Inhibitor -Pipeline Insight, 2018
From $1,250.00
Global Tree Nuts Market Research Report - Forecast to 2022
From $4,450.00
Global Biomarker Partnering 2014-2020
From $3,495.00
Bladder Cancer: KOL Insight [2018]
From $8,495.00
Digital Therapeutics: Taking digital health to a new level
From $395.00
Biosimilars in Emerging Markets (2018)
From $2,495.00
Gene Therapy in Oncology
From $7,995.00
AI: Show me the Money Which sectors will make a killing in AI Forecast 2017 - 2023
From $1,850.00
Global Human Microbiome Market Forecast 2018-2026
From $2,500.00
Operating Room Equipment - Medical Devices Pipeline Assessment, 2018
From $2,500.00
Patient Examination Devices - Medical Devices Pipeline Assessment, 2018
From $2,500.00
Challenges in Immuno-oncology (I-O): Future Use, Trial Design and Combination Strategies
From $4,995.00
Gene Therapies: A Growing Pipeline and Approval of CAR-T Cell Therapies
From $2,995.00
Second-Generation Cell and Gene-based Therapies
From $165.00
Microfluidics in Cell Biology Part C - Microfluidics on a Molecular Scale, Volume 148
From $175.00
Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2018
From $2,995.00
Clinical Stage Partnering Terms and Agreements in Pharma and Biotech 2014-2019
From $2,995.00
Building Digital Assistants, Virtual Agents, and Chatbots: A Vendor Guide
From $1,995.00
KAM Metrics: Driving efficiency and measuring success
From $2,495.00
Single-use Bioprocessing Market by Product
From $4,250.00
Single-use Bioprocessing Systems Market, by Product Type
From $4,500.00
Competitor Analysis: Tumor Microenvironment Modulation via IDO, TGF-ß, CXCR4, CSF-1R, CD47-SIRPa, adenosine pathway & STING 2018
From $927.04
Competitor Analysis: CD40, GITR, OX40, 4-1BB, CD27, ICOS & Other Immune Checkpoint Activators 2018
From $579.40
Competitor Analysis: CTLA-4, LAG-3, TIM-3, TIGIT & Other Immune Checkpoint Inhibitors 2018
From $579.40
Competitor Analysis: PD-1 and PD-L1 Immune Checkpoint Inhibitors 2018
From $695.28
Global Big Pharma Partnering Terms and Agreements 2014-2020: Deal trends, players and financials
From $3,495.00
Optruma API Insight 2018
From $500.00
Cancer Nanotechnology, Volume 139
From $171.00
Advances in Clinical Chemistry, Volume 87
From $205.00
Medicinal Chemistry Approaches to Overcome Antibiotic Resistance, Volume 51
From $175.00
Advances in Applied Microbiology, Volume 105
From $142.00
Cancer Therapy and Diagnosis Part B, Volume 44
From $159.00
Patient Enrollment and Recruitment Market Study 2018
From $399.00
Global Diagnostics Partnering 2020: Deal trends, players, financials and forecasts
From $3,495.00
Global Licensing Terms & Agreements in Pharma, Biotech & Diagnostics
From $3,495.00
Global Bioinformatics Partnering Terms & Agreements
From $2,995.00
The Development of Therapeutic Monoclonal Antibody Products
From $385.00
Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2014-2020
From $3,495.00
Global Molecular Diagnostics Partnering Terms and Agreements 2014 to 2020
From $3,495.00
Global Regenerative Medicine Partnering 2014-2020: Deal trends, players, financials and forecasts
From $3,495.00
Global Biotech Partnering Terms and Agreements 2014-2019: Deal trends, players and financials
From $2,995.00
Global Pharmaceutical Partnering Terms and Agreements 2014-2020: Deal trends, players and financials
From $3,495.00
Global Monoclonal Antibody Partnering Terms and Agreements 2014 to 2020
From $3,495.00
Global Central Nervous System Partnering 2014 to 2019: Deal trends, players and financials
From $3,495.00
Preclinical Stage Partnering Terms and Agreements 2014-2020
From $3,495.00
View All Reports

Report Topics

Publishers
CHI | Cambridge HealthTech Institute

250 First Avenue, Suite 300
Needham, MA 02494

P: 781.972.5400
F: 781.972.5425
E: chi@

Copyright © 2021 Insight Pharma Reports. All rights reserved.
Powered by nopCommerce

© 2021 bob综合-沈阳泰达文化传媒有限公司 辽ICP备16010226号